QuidelOrtho Corporation
QDEL | NASDAQ
$10.86
+$0.24 (+2.26%)
At close: Sep 21, 2026, 4:00 PM ET
$10.86
$0 (0.00%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
Fiscal Year Period Ending | FY 2025 Dec 27, 2025 | FY 2024 Dec 28, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 2.73B | 2.78B | 3B | 3.27B | 1.7B | 1.66B |
Cost of Revenue | 1.46B | 1.5B | 1.5B | 1.33B | 420.3M | 312.81M |
Gross Profit | 1.27B | 1.29B | 1.5B | 1.94B | 1.28B | 1.35B |
Operating Income | -919.2M | -1.96B | 139.1M | 843.7M | 906M | 1.06B |
Interest Income | n/a | n/a | 2.2M | 1.3M | 300K | n/a |
Pretax Income | -1.11B | -2.13B | -29.1M | 735.9M | 900.3M | 1.04B |
Net Income | -1.13B | -2.05B | -10.1M | 548.7M | 704.2M | 810.29M |
Selling & General & Admin | 746.3M | 766.8M | 763.2M | 621M | 239.6M | 200.54M |
Research & Development | 186.2M | 218.7M | 246.8M | 187.9M | 95.7M | 84.29M |
Other Expenses | 1.26B | 2.26B | 349.8M | 283.6M | 37M | 3.69M |
Operating Expenses | 2.19B | 3.25B | 1.36B | 1.09B | 372.3M | 288.53M |
Interest Expense | 177.6M | 188.3M | 178.9M | 74.5M | 700K | 1.26M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | 13.7M | 133.96M |
Cost & Expenses | 3.65B | 4.74B | 2.86B | 2.42B | 792.6M | 601.34M |
Income Tax Expense | 24.1M | -79.5M | -19M | 187.2M | 196.1M | 230.03M |
Shares Outstanding (Basic) | 67.8M | 67.2M | 66.8M | 56.8M | 42.08M | 42.12M |
Shares Outstanding (Diluted) | 67.8M | 67.2M | 66.8M | 57.4M | 42.87M | 43.59M |
EPS (Basic) | -16.69 | -30.54 | -0.15 | 9.66 | 16.74 | 19.24 |
EPS (Diluted) | -16.69 | -30.54 | -0.15 | 9.56 | 16.43 | 18.60 |
EBITDA | -488.1M | -1.49B | 607M | 1.09B | 953.3M | 1.1B |
EBIT | -930.1M | -1.94B | 149.8M | 810.4M | 900.6M | 1.05B |
Depreciation & Amortization | 442M | 453.4M | 457.2M | 283.6M | 52.7M | 49.09M |
Add to Watchlist
Select watchlists to add or remove QDEL